Oxalatfosfat

Na2Fe ( C2O4 ) ( HPO4 ) kristallstruktur _

Oxalatfosfaterna är kemiska föreningar som innehåller oxalat och fosfatanjoner . De kallas också oxalatofosfater eller fosfatoxalater. Vissa oxalat-fosfatmineraler som finns i fladdermusguanoavlagringar är kända. Oxalatfosfater kan bilda metallorganiska ramverksföreningar .

Besläktade föreningar inkluderar arsenatoxalater och fosfitoxalater, oxalatometylfosfonat och potentiellt andra oxalatfosfonater.

Lista

namn chem mw kristallsystem rymdgrupp enhetscell Å volym densitet kommentar referenser
Phoxite (NH 4 ) 2 Mg 2 (C 2 O 4 ) (PO 3 OH) 2 (H 2 O) 4 monoklinisk P21 / c _ a=7,2962 b=13,5993 c=7,8334 β =108,271° Z=2 738,07 1,98 mineral biaxiell (-) a = 1,499, p = 1,541 y = 1,542; 2V = 16
Thebanit-( NH4 ) (NH4 , K ) 3Al ( C2O4 ) ( PO3OH ) 2 ( H2O ) monoklinisk P21 / c _ a = 11,156, b = 6,234, c = 18,65, p = 102,93°, Z=4 1264 2,093 biaxiell (–) a = 1,490, β = 1,534, y = 1,570; 2V = 82,7°
bis(N-metylpiperazindi-ium) bis(bis(μ-divätefosfato)-(oxalato)-skandium)oxalattrihydrat H2mpip⋅Sc ( H2PO4 ) 2 ( C2O4 ) · 0,5C2O4 · 1,5H2O _ _ _ _ _ _ _ C 2 a =17,1307 b =6,6277 c =16,3543 β= 103,336°
Davidbrownite (NH4 ) , (NH4 , K ) 5 ( V4 + O) 2 ( C2O4 ) [ PO4H ] 3 · [PO4H2 ] · 3H2O monoklinisk P21 / c _ a = 10,356, b = 8,923, c = 13,486, p = 92,618°, Z = 2 1244,9 2.12 grön-blå mineral biaxiell (+) α = 1,540, β = 1,550 γ = 1,582; 2V = 58,5
( NH4 ) 2 VO ) 2 ( HPO4 ) 2C2O4 ] · 5H2O Li2 ( (
) VO ) 2 ( HPO4 ) 2 C2O4 [ ( _ _
Li2 ( VO ) 2 ( HPO4 ) 2 ( C2O4 ) · 6H2O _ 535,84 triklinik a = 6,4133 b = 9,2173, c = 14,6206 a = 95,016°, p = 91,797°, y = 107,7622° och Z = 2 818,38 2,1743
Na2 [ ( VO ) 2 ( HPO4 ) 2C2O4 ] .2H2O _ _ _ monoklinisk P 2 1 a = 6,3534, b = 17,1614, c = 6,5632, β = 106,59 arkmorfologi
K 2 [(VO) 2 (HPO 4 ) 2 (C 2 O 4 )] 492,05 triklinik a=6,316 b=7,489 c=10,861 a=56,8° β=57,99° γ=54,20°
K2 [ ( VO) 2 ( HPO4 ) 2 ( C2O4 ) ] · 4,5H2O triklinik P 1 a = 6,3953, b = 9,1451, c = 14,6208, a = 97,269°, p = 91,351° y = 106,500° Z=2
K 2,5 [ (VO) 2 ( HPO4 ) 1,5 ( PO4 ) 0,5 ( C2O4 ) ] MOF
LiK[(VO ) 2 ( HPO4 ) 2 ( C2O4 ) ] · 4,5H2O
( C2H10N2 ) [ VO ( HPO4 ) ] 2 ( C2O4 ) _ _ 473,96 triklinik P 1 a = 6,3595, b = 6,6236, c = 9,224, a = 98,216 o , p = 108,128 o , y = 100,672 o , Z = 1 354,42 2,225
guanidinvanadylvätefosfatoxalat (CH 6 N 3 ) 2 [VO(HPO 4 )] 2 (C 2 O 4 ) 532,02 triklinik P 1 a = 6,3825, b = 7,8877, c = 9,202, a = 66,602 o , p = 71,757 o , y = 79,821 o , Z = 1 403,07 2,192
catena-(4,4'-Bipyridinium bis(μ 3 -vätefosfato)-(μ 2 -oxalato)-dioxo-di-vanadium) ( C10H10N2 ) [ ( VO ) ( HPO4 ) ] 2 ( C2O4 ) monoklinisk P 2 1 / c a= 9,250 b = 6,338 c= 16,111, p= 98,08°
K 2 Mn II 2 (H 2 O) 2 C 2 O 4 (HPO 3 ) 2 oxalofosfit
TREN = tris(2-aminoetyl)amin) ( H3TREN ) [ Mn2 ( HPO4 ) ( C2O4 ) 2,5 ] · 3H2O triklinik P 1 a = 8,8385, b = 9,0586, c = 16,020, a = 77,616°, p = 83,359°, y = 68,251° och Z = 2.
mpipl-metylpiperazin ( H 2 mpip) 1,5 • Mn3 ( HPO4 ) ( H2PO4 ) ( C2O4 ) 2
dap=1,2-diaminopropan (H 2 dap)•Mn 3 (HPO 4 ) (H 2 PO 4 ) (C 2 O 4 ) 2
pa = propylamin (Hpa)•Mn 3 (HPO 4 ) (H 2 PO 4 ) (C 2 O 4 ) 2
dmp = 1,4-dimetylpiperazin ( H2 dmp ) 0,5 · Mn ( H2PO4 ) ( C2O4 ) triklinik P 1 a =5,8528 b =8,1833 c =11,1334, α =103,958° β =93,550° γ =90,572°
TREN = tris(2-aminoetyl)amin) ( H3TREN ) [ Fe2 ( HPO4 ) ( C2O4 ) 2,5 ] · 3H2O triklinik P 1 a = 8,7776, b = 8,9257, c = 15,884, a = 78,630°, p = 84,018° och y = 67,372° Z=2
1,3-diaminopropan [ C3H12N2 ] 2 [ Fe5 ( C2O4 ) 2 ( H x PO4 ) 8 ] _ _ _ _ _ _ 1367,31 triklinik P 1 a=9,7851 b=9,8986 c=10,7420 α =73,790 β = 71,684 γ = 79,300 Z=1 942,99 2,408
Na2Fe ( C2O4 ) ( HPO4 ) _ _ monoklinisk P21 / c a=6,4728, b=20,210, c=10,4712 β= 90,745 1369,7 orange
K 2 Fe(C 2 O 4 ) (HPO 4 ) (OH 2 ) · H 2 O 354,08 ortorombisk Pbca a=11,880 b=10,384 c=15,337 Z=8 1891.9 2,486 gul
[ NH3 ( CH2 ) 3NH3 ] [ Zn6 ( PO4 ) 4 ( C2O4 ) ] _ _ 456,12 triklinik P 1 a =5,0030 b=8,5434 c=12,4336 α=92,99 β=97,138 γ = 91,465 Z=2 526,33 2,878
MIL-90 pentagallium seskvitrimetylendiamin difluorid dihydroxi oxalat tetrafosfat Ga5 ( PO4 ) 4 ( C2O4 ) F2 ( OH ) 2 · 1,5N2C3H12 _ _ _ _ _ triklinik P 1 a = 8,1217, b = 8,9601, c = 10,4611, a = 111,930°, p = 103,655°, y = 101,903° 648,59
NTHU-6 2 ( C13H16N2 ) Ga108 ( PO4 ) ( HPO4 ) 4 ( OH ) 2 ( C2O4 ) .3 ( H2O ) 2251,61 monoklinisk C 2/ m a=23,048 b=24,649 c=17,081 β = 132,192 Z=4 7189,8 2,080 gul
1,3-diaminopropan [ Ga2 ( PO4 ) 2 ( H2O ) ( C2O4 ) 0,5 ] ( C3N2H12 ) 0,5 ( H2O ) _ _ _ _
etylendiamin [ Ga2 ( PO4 ) 2 ( C2O4 ) 0,5 ] ( C2N2H10 ) 0,5 ( H2O ) _ _ _ _ _
1,3-diaminopropan [ Ga2 ( PO4 ) 2 ( C2O4 ) 0,5 ] ( C3N2H12 ) 0,5 _ _ _ _ _
dietylentriamin [ Ga2 ( PO4 ) 2 ( H2PO4 ) 0,5 ( C2O4 ) 0,5 ] ( C4N3H16 ) 0,5 ( H2O ) 1,5 _ _ _ _ _ _ _
dietylentriamin [ Ga 2,5 ( PO4 ) 2,5 ( H2O ) 1,5 ( C2O4 ) 0,5 ] ( C4N3H15 ) 0,5 _ _ _ _
dmpip = 2,6-dimetyl-piperazin

catena-(bis(2,6-dimetylpiperazin-1,4-di-ium) bis(μ-vätefosfato)-bis(μ-fosfato)-(μ-oxalato)-bis(vätefosfat)-tetra-galliumdihydrat

 [H2 dmpip ] [ Ga2 ( HPO4 ) 2 ( PO4 ) ( C2O4 ) 0,5 ] · H2O monoklinisk P21 / c _ a 8,904 b 28,036 c 8,173, β =100,74°
catena-(2-(3-ammoniopropyl)propan-1,3-diammonium bis(μ 4 -fosfato)-bis(μ 3 -fosfato)-(μ 2 -oxalato)-(μ 2 -monovätefosfato)-tetra- galliumdihydrat) [ C6N3H19 ] [ Ga4 ( C2O4 ) ( PO4 ) 4 ( H2PO4 ) ] · 2H2O _ _ _ _ _ monoklinisk C 2/ c a =20,355 b =15,649 c =9,0517 β =105,781°
Piperazindiium bis(μ2 - oxalato-O,O',O'',O''')-bis(μ2 - vätefosfato-O,O')-diaqua-di-indiumdihydrat [ C4N2H12 ] 0,5In ( HPO4 ) ( C2O4 ) .H2O _ _ _ _ monoklinisk P21 / c a =6,4726 b =11,080 c =14,311, β =100,316°
Piperazinium bis(μ 3 -monhydrogenfosfato)-(μ 2 -monohydrogenfosfato)-(μ 2 -oxalato)-di-indium monohydrat [ C4H12N2 ] [ In2 ( C2O4 ) ( HPO4 ) 3 ] · H2O _ _ _ _ monoklinisk P2 1 a =6,5052 b =17,5005 c =8,1811 β =107,656
dmp = 1,4-dimetylpiperazin

bis(1,4-dimetylpiperazin-1,4-diium)bis(μ-oxalato)-tetrakis(μ-divätefosfato)-tetrakis(μ-vätefosfato)-tetra-indium(iii)dihydrat

 H 2 dmp·In 2 (HPO 4 ) 2 (H 2 PO 4 ) 2 (C 2 O 4 ) · H 2 O a 7,9684 b 11,9582 c 12,5204, α 89,946° β 84,035° γ 87,287°
dmapa = 3-(dimetylamino)-1-propylamin H 2 dmapa·In 2 (HPO 4 ) 2 (H 2 PO 4 ) 2 (C 2 O 4 ) · H 2 O a 7,8398 b 12,0428 c 12,4877, α 90,013° β 96,335° γ 92,640°
Cs 2 Fe(C 2 O 4 ) 0,5 (HPO 4 ) 2
CsFe (C 2 O 4 ) 0,5 (H 2 PO 4 ) (HPO 4 )
APPIP = 1,4-bis(3-aminopropyl)piperazin ( H4APPIP ) [ Er3 ( C2O4 ) 5,5 ( H2PO4 ) 2 ] · 5H2O _ _ _
APPIP = 1,4-bis(3-aminopropyl)piperazin ( H4 APPIP ) [ Tm3 ( C2O4 ) 5,5 ( H2PO4 ) 2 ] · 5H2O _ _
APPIP = 1,4-bis(3-aminopropyl)piperazin ( H4 APPIP ) [ Yb3 ( C2O4 ) 5,5 ( H2PO4 ) 2 ] · 5H2O _ _
APPIP = 1,4-bis(3-aminopropyl)piperazin ( H4APPIP ) [ Lu3 ( C2O4 ) 5,5 ( H2PO4 ) 2 ] · 5H2O _ _ _
K 4 [Th(HPO 4 ) 2 (C 2 O 4 ) 2(H 2 O) 2 ]•4Н 2 O
Plutonium(IV)oxalatofosfat ?
Hämtad från " https://en.wikipedia.org/w/index.php?title=Oxalate_phosphate&oldid=1139796378 "